Home » Trials » SLCTR/2015/021


Impact of life style adjustments on glycaemic status and surrogate markers of diabetes mellitus in postpartum women with diagnosed Gestational Diabetes Mellitus (GDM)

-

SLCTR Registration Number

SLCTR/2015/021


Date of Registration

25 Sep 2015

The date of last modification

Oct 04, 2024


Trial Status



Application Summary


Scientific Title of Trial

Impact of life style adjustments on glycaemic status and surrogate markers of diabetes mellitus in postpartum women with diagnosed Gestational Diabetes Mellitus (GDM)


Public Title of Trial

Life style adjustment in Gestational Diabetes Mellitus (GDM)


Disease or Health Condition(s) Studied

Gestational diabetes


Scientific Acronym

None


Public Acronym

None


Brief title

Study of the impact of lifestyle adjustment in Gestational Diabetes mellitus


Universal Trial Number

U1111-1168-4119


Any other number(s) assigned to the trial and issuing authority

ERC/University of Sri jayewardenapura 52/14


Trial Details


What is the research question being addressed?

What is the association between exercise ad dietary intervention with insulin resistance and inflammatory response in postpartum women with diagnosed GDM?


Type of study

Interventional


Study design

Allocation

Randomized controlled trial


Masking

Masking not used


Control

Standard therapy/practice


Assignment

Parallel


Purpose

Prevention


Study Phase

Not Applicable


Intervention(s) planned

The study will be carried out at the Castle Street Hospital for Women and the De Soysa Maternity Hospital.

Participants will be invited to attend a special clinic in the department of Clinical Medicine, Colombo for data collection.

A total of 100 postpartum women who meet the inclusion and exclusion criteria will be recruited soon after delivery (before discharge) from Castle Street Maternity Hospital for Women and De Soysa Maternity Hospital. Each of the 12 clinics will be randomized (cluster randomization) to be allocated either intervention or routine care (control). The participants registered at each clinic, will thus be allocated accordingly to the two arms.

Arm A: Intervention arm (diet and physical activity modifications counseling) 1. Participants will undergo standardized individual counselling sessions by a trained investigator, lasting 30-60 minutes each. Session will address diet and exercise and a customized plan will be given. 2. Participants will be reviewed every 3 months for one year (total of 4 visits, including at the initial session). Diet and exercise plan will be adjusted based on pre-determined criteria in the outcomes. Based on pre-determined criteria, further counselling sessions lasting 30-60 minutes will be offered. 3. Standard management according to clinic protocols will continue.

Arm B: Control arm Participants will receive only standard management according to clinic protocols.


Inclusion criteria

  1. Postpartum women in para 1
  2. Singleton pregnancy
  3. Delivery of a healthy normal infant
  4. Diagnosis of GDM defined as carbohydrate intolerance resulting in hyperglycemia, with onset or first recognition during pregnancy (American Diabetic Association cut-offs)

Exclusion criteria

  1. Continuation of anti-diabetic medication after delivery
  2. Conception by assisted reproductive techniques
  3. History of any other chronic medical illness needing long term medication
  4. Chronic infection
  5. Acute infection within one month prior to delivery


Primary outcome(s)

1.
  1. Fasting blood glucose
  2. OGTT
  3. Fasting Insulin
  4. Hs-CRP (high sensitivity C reactive protein)
  5. Insulin resistance (HOMA-IR homeostasis model assessment)
[
  1. Fasting blood glucose at baseline, 6 months and 12 months
  2. All other outcomes at baseline and 12 months
]

Secondary outcome(s)

1.
  1. Anthropometric measurements (weight, height, waist and hip circumferences)
  2. Assessment of dietary practices - 3 day diet diary, 24 hour dietary recall.
  3. Assessment of activity level by iPAQ and pedo-meter.
[

Every 3 months for a total of 12 months

]

Target number/sample size

100 (50 in each arm)


Countries of recruitment

Sri Lanka


Anticipated start date

2015-10-01


Anticipated end date

2017-04-01


Date of first enrollment

2016-01-01


Date of study completion

2018-10-06


Recruitment status

Complete: follow up complete


Funding source

University of Sri Jayewardenapura (Grant no. ASP/06/RE/MED/2013/39)


Regulatory approvals



State of Ethics Review Approval


Status

Approved


Date of Approval

2014-11-12


Approval number

52/14


Details of Ethics Review Committee

Name: Ethics Review Committee, Faculty of Medical Sciences, University of Sri Jayewardenepura
Institutional Address:Gangodawila, Nugegoda Sri Lanka
Telephone:+94-112758000 (Extension: 4075)
Email: erc.fms.usjp@gmail.com

Contact & Sponsor Information


Contact person for Scientific Queries/Principal Investigator

S.M.T.D Sundarapperuma
Lecturer
B.Sc Nursing Degree Programme, Faculty of Medicine, University of Ruhuna
Tel: 0912243241
Mob: 0713186524

chamudi2006@yahoo.com

Contact Person for Public Queries

Prof P. Hettiarachchi
Professor
Department of Physiology Faculty of Medical Sciences University of Sri Jayewardenapura

Mob: 0718432344

priyadarshikahett@gmail.com


Primary study sponsor/organization

University of Sri Jayewardenapura

Gangodawila, Nugegoda, Sri Lanka.
Tel: +94 11 2758000, +94 11 2802022, +94 11 2801024,
Fax: +94 11 2801025

http://www.sjp.ac.lk

Secondary study sponsor (If any)

None





Trial Completion details


Do the investigators plan to share identified individual clinical trial participant-level data (IPD)?


IPD sharing plan description


Study protocol available


Protocol version and date

Not Available


Protocol URL

Not Available


Results summary available

Yes


Date of posting results


Date of study completion

2018-10-06


Final sample size

70


Date of first publication

2018-08-26


Link to results


Brief summary of results

Results showed that the insulin resistance (median) was significantly lower in the intervention group (0.98) compared to the controls (1.94) at 12 months postpartum. Although anthropometric measurements (weight, waist circumference, WHR, WHtR) and glycemic parameters (FBG, OGTT, HbA1c) were comparable at baseline in both groups, they were significantly lower in the intervention group compared to the control group at 12 months. The impact of the intervention on inflammation was inconclusive.